A randomized controlled trial of recombinant interferon α-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C

Journal of Hepatology

Volumn 21, Issue 5, 1994, Pages 831-836

  Hwang, Shinn Jang ^a,b   Lee, Shou Dong ^a,b   Chan, Cho Yu ^a,b   Lu, Rei Hwa ^a,b   Lo, Kwang Juei ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

acute; Branched DNA signal amplification; Hepatitis C viral RNA; Interferon 2b; Polymerase chain reaction; post transfusion; quantitation; recombinant; Viral hepatitis C

Indexed keywords

ALANINE AMINOTRANSFERASE; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ACUTE HEPATITIS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; HEPATITIS B; HEPATITIS C; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ACUTE DISEASE; BASE SEQUENCE; BLOOD TRANSFUSION; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON ALFA-2B; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NUCLEIC ACID AMPLIFICATION TECHNIQUES; OLIGONUCLEOTIDE PROBES; POLYMERASE CHAIN REACTION; RNA, VIRAL; TRANSCRIPTION, GENETIC;

EID: 0028051631     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(94)80246-7     Document Type: Article

References (27)

1. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
2. An assay for circulating antibodies to a major etiologic virus of non-A, non-B hepatitis
3. Posttransfusion non-A, non-B hepatitis following cardiovascular surgery in Taiwan
4. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis
5. Non-A non-B hepatitis evolving epidemiologic and clinical perspective
6. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus
7. Treatment of chronic hepatitis C with recombinant interferon alfa, a multicenter randomized, controlled trial
8. Recombinant interferon alfa therapy for chronic hepatitis C, a randomized, double-blind, placebo-controlled trial
9. Recombinant human α-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France
10. A randomized controlled clinical trial of recombinant interferon α-2b in the treatment of acute post-transfusion hepatitis C — a preliminary report
11. The 5′terminal sequence of the hepatitis C virus genome
12. Avoiding false positive with PCR
13. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C
14. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources
15. Recombinant α-interferon for chronic non-A, non-B hepatitis: optimal dose and factors associated with favorable response
16. A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitis
17. Resolution of acute hepatitis C after therapy with natural beta interferon
18. Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status
19. Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C
20. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C
21. Effects of interferon-α on serum hepatitis C virus in patients with chronic hepatitis C
22. Interferon-α in acute posttransfusion hepatitis C: a randomized, controlled trial
23. A randomized, multicenter, controlled trial of recombinant interferon alpha 2b in patients with acute posttransfusion non-A, non-B hepatitis (PTH)
24. Treatment of posttransfusion non-A, non-B acute and chronic hepatitis with human fibroblast α-interferon: a preliminary report
25. Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis
26. The declining risk of post-transfusion hepatitis C virus infection
27. Incidence of post-transfusion hepatitis before and after screening for HCV antibody